27+ min ago  (452+ words) ROCHESTER, N. Y. "The use of GLP-1 medications for weight loss has skyrocketed, but there are side effects. One woman is sharing her experience with the medication and her weight loss success story. "I had high cholesterol, high blood pressure, sleep apnea....

1+ hour, 37+ min ago  (347+ words) May 28 (Reuters) " CVS Health will add Eli Lilly's weight-loss drug Zepbound back to some of its drug lists as an additional preferred option and also begin coverage for "the drugmaker's newly approved obesity pill, Foundayo. CVS' Caremark, one of "the…...

29+ min ago  (13+ words) Toledo Blade...

41+ min ago  (806+ words) May 28, 2026 "|" Emily Bleiweis Three years ago, Debi Hudgens, Ph D, MBA, CLP, CA-AM, was diagnosed with a rare renal disease. Hudgens is fortunate, she said " there are new medications that have come out in recent years that are helping. But…...

2+ hour, 39+ min ago  (262+ words) The bill regulating virtual pharmacies was passed in the first reading logos-pres. md The bill regulating virtual pharmacies was passed in the first reading Until now, national legislation did not have clear provisions on the sale of medicines over the…...

44+ min ago  (265+ words) Published - May 28, 2026 10: 24 pm IST - Nairobi A vaccine against the Bundibugyo strain of the Ebola virus will be ready by the end of the year, the Director General of Africa Centres for Disease Control and Prevention (Africa CDC) said on Thursday (May…...

38+ min ago  (1287+ words) May 28, 2026, 13: 00 ET Phase 3 ACHIEVE results showed Foundayo, an oral GLP-1 taken without food or water restrictions, outperformed oral semaglutide and dapagliflozin in type 2 diabetes, reinforcing its potential to redefine oral incretin therapy New analyses of the ATTAIN program highlight Foundayo's…...

1+ hour, 39+ min ago  (447+ words) May 28 (Reuters) " The U. S. FDA's advisory panel will vote on Thursday on whether COVID-19 vaccines for the 2026-2027 immunization campaign should target the dominant XFG variant, after staff members raised concerns about limited data "on currently circulating strains. The Food and Drug…...

1+ hour, 47+ min ago  (528+ words) Rubedo's RLS-1496 reduces actinic keratoses (AK) by 46% at four weeks with minimal irritation in preliminary results of Phase 1b/2a study, according to interim results from a Phase 1b/2a study. RLS-1496 is an investigational, first-in-class, disease-modifying, selective glutathione peroxidase 4 (GPX4) modulator that targets pathologic…...

49+ min ago  (22+ words) The Times of India - No vaccine yet for crop virus diseases: Prof Rajasab...